Product
The Triple Threat
Retatrutide
The next evolution in metabolic support for those who want more than GLP-1 alone.
A triple-agonist peptide that works across three metabolic pathways simultaneously – GLP-1, GIP, and glucagon – for the most comprehensive approach to weight loss currently available. Retatrutide goes beyond appetite suppression, directly targeting fat metabolism and energy expenditure for results that are faster, deeper, and more complete.
UNEARTHED QUALIFIERS
Premium Quality
Lab tested for quality to promote patient safety
No insurance required
Size
What is Retatrutide?
Retatrutide is a next-generation triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously. While GLP-1 peptides work on appetite and dual-agonists add metabolic support, retatrutide adds a third pathway - glucagon receptor activation - which directly enhances fat burning and energy expenditure. It is the most advanced compounded metabolic peptide currently available.
What are the benefits?
- Works across three metabolic pathways for comprehensive results
- Supports significant, faster weight loss beyond GLP-1 alone
- Directly enhances fat burning through glucagon activation
- Helps regulate appetite, blood sugar, and metabolic function
- Best option for those who have not achieved desired results with other GLP peptides
- Supports body recomposition alongside fat loss
Who it’s best for?
Those looking for the most advanced weight loss support available especially if you have already tried GLP-1 or dual-agonist peptides and want a more powerful, comprehensive approach to fat loss and metabolic optimization.